Navigating 6 Analyst Ratings For AtriCure
Portfolio Pulse from Benzinga Insights
Analysts' ratings for AtriCure (NASDAQ:ATRC) have varied from bullish to bearish over the last quarter. The average 12-month price target has decreased from $44.50 to $37.17. Recent analyst actions include several downgrades in price targets.
July 31, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AtriCure (NASDAQ:ATRC) has seen mixed analyst ratings over the last quarter, with the average 12-month price target decreasing from $44.50 to $37.17. Recent downgrades in price targets by several analysts reflect evolving market conditions and company performance.
The decrease in the average 12-month price target from $44.50 to $37.17 and multiple downgrades in price targets by analysts suggest a negative short-term impact on AtriCure's stock price. This reflects evolving market conditions and company performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100